Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
7.02
-0.28 (-3.84%)
Feb 21, 2025, 4:00 PM EST - Market closed
Apollomics Market Cap
Apollomics has a market cap or net worth of $7.74 million as of February 21, 2025. Its market cap has decreased by -85.13% in one year.
Market Cap
7.74M
Enterprise Value
-13.47M
1-Year Change
-85.13%
Ranking
Category
Stock Price
$7.02
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $7.74M, a decrease of -94.03%. That is a compound annual growth rate of -58.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 7.74M | -28.00% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |